US0008991046
US0008991046
ADMA Biologics Inc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.32B EUR | 1.89B EUR | 2.09B EUR | 4.34B EUR |
Enterprise Value | 2.38B EUR | 1.95B EUR | 2.16B EUR | 4.33B EUR |
Valuation Multiples | ||||
Trailing P/E | 14.8x | 11.16x | 12.66x | 36.15x |
Forward P/E | 10.98x | -- | -- | -- |
Price to Sales | 4.53x | 3.68x | 4.1x | 10.97x |
Price to Book | 5.72x | 4.62x | 5.36x | 9.09x |
EV/Revenue | 4.65x | 3.81x | 4.23x | 10.95x |
EV/EBITDA | 10.62x | 8.6x | 9.96x | 26.44x |
Price to FCF (P/FCF) | 42.38x | 16.23x | 19.46x | 83.6x |
EV/FCF | 43.49x | 16.81x | 20.08x | 83.45x |
FCF Yield | 2.36% | 6.16% | 5.14% | 1.2% |